Medicare Enrolled

Dr. Shant Manoushagian, M.D.

Cardiovascular Disease · Fort Myers, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
9981 S HEALTHPARK DR, Fort Myers, FL 33908
2393436860
In practice since 2012 (13 years)
NPI: 1205191699 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Manoushagian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Manoushagian? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Manoushagian

Dr. Shant Manoushagian is a cardiovascular disease in Fort Myers, FL, with 13 years in practice. Based on federal Medicare data, Dr. Manoushagian performed 1,046 Medicare services across 794 unique beneficiaries.

Between the years covered by Open Payments, Dr. Manoushagian received a total of $6,464 from 15 pharmaceutical and/or device companies across 73 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Manoushagian is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years in practice▲ 1,046 Medicare services$ $6,464 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,046
Medicare services
Bottom 27% in FL for cardiovascular disease
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
794
Unique beneficiaries
$19
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~80 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
EKG interpretation and report848$7$44
Electrocardiogram (EKG), 12-lead46$14$145
Office visit, established patient (30-39 min)44$115$550
Ultrasound of heart with color-depicted blood flow, rate and valve function25$3$60
Hospital follow-up visit, high complexity21$111$715
Echocardiogram, transthoracic19$184$1,935
Ultrasound of heart, follow-up16$22$215
Ultrasound of heart blood flow, valves and chambers, follow-up15$7$115
Initial hospital admission, moderate complexity12$122$700
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
5.6% high complexity
1.5% medium
92.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$6,464
Total received (2018-2024)
Avg $923/year across 7 years
Top 33% in FL for cardiovascular disease
15
Companies
73
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,464 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,081
2023
$1,458
2022
$1,822
2021
$604
2020
$465
2019
$749
2018
$285

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$2,158
HEARTFLOW, INC.
$741
Siemens Medical Solutions USA, Inc.
$715
CVRx, Inc.
$574
Boehringer Ingelheim Pharmaceuticals, Inc.
$468
AstraZeneca Pharmaceuticals LP
$464
Novartis Pharmaceuticals Corporation
$365
HeartFlow, Inc.
$342
BIOTRONIK INC.
$192
Arineta, Inc
$162
Alnylam Pharmaceuticals Inc.
$125
PFIZER INC.
$63
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$44
Amgen Inc.
$35
Janssen Pharmaceuticals, Inc
$15
Top 3 companies account for 55.9% of total payments
Associated products mentioned in payments ›
ACUSON S2000 Diagnostic Ultrasound System · ACUSON SC2000 Diagnostic Ultrasound System · AMPLATZER AMULET · Barostim Neo System · CARDIOMEMS · CardioGraphe · CardioMEMS HF System · Corlanor · ELIQUIS · ENTRESTO · FARXIGA · FFRct · HeartMate · HeartMate 3 Left Ventricular Dev · JARDIANCE · LEQVIO · LifeVest · MITRACLIP · Mitra Clip system · ONPATTRO · Repatha · SOMATOM Pro.Pulse · System SOMATOM Drive · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · VYNDAQEL · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $618 per 100 Medicare services performed
Looking for a cardiovascular disease in Fort Myers?
Compare cardiovascular diseases in the Fort Myers area by procedure volume, costs, and industry payment transparency.
Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi
82
Per 100K population
10.3
County median income
$73,099
Nearest hospital
PARK ROYAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Manoushagian is a mixed practice specialist, with moderate Medicare volume, and low-engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Manoushagian experienced with ekg interpretation and report?
Based on Medicare claims data, Dr. Manoushagian performed 848 ekg interpretation and report services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Manoushagian receive payments from pharmaceutical companies?
Yes. Dr. Manoushagian received a total of $6,464 from 15 companies across 73 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Manoushagian's costs compare to other cardiovascular diseases in Fort Myers?
Dr. Manoushagian's average Medicare payment per service is $19. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Manoushagian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →